SEC, FDA Sign Agreement to Boost Information Sharing, Market Oversight
MT Newswires Live
Sep 01
The Securities and Exchange Commission said Monday that it has entered into a three-year memorandum of understanding with the Food and Drug Administration to strengthen cooperation on regulatory and enforcement matters, including information sharing relevant to both agencies.
The agreement is intended to improve market oversight and compliance while supporting the FDA's public health mission, the agency said.
"FDA-related disclosures by public companies have a significant impact on our markets," SEC Chairman Paul Atkins said, adding that the MOU will strengthen efforts to "enforce applicable disclosure requirements under the federal securities laws."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.